Search

In this article, we develop a Bayesian hierarchical mixture regression model for studying the association between a multivariate response, measured as counts on a set of features, and a set of covariates. We have available RNA-Seq and DNA methylation data measured on breast cancer patients at different stages of the disease. We account for the heterogeneity and over-dispersion of count data (here, RNA-Seq data) by considering a mixture of negative binomial distributions and incorporate the covariates (here, methylation data) into the model via a linear modeling construction on the mean components. Our modeling construction includes several innovative characteristics. First, it employs selection techniques that allow the identification of a small subset of features that best discriminate the samples while simultaneously selecting a set of covariates associated to each feature. Second, it incorporates known dependencies into the feature selection process via the use of Markov random field (MRF) priors. On simulated data, we show how incorporating existing information via the prior model can improve the accuracy of feature selection. In the analysis of RNA-Seq and DNA methylation data on breast cancer, we incorporate knowledge on relationships among genes via a gene-gene network, which we extract from the KEGG database. Our data analysis identifies genes which are discriminatory of cancer stages and simultaneously selects significant associations between those genes and DNA methylation sites. A biological interpretation of our findings reveals several biomarkers that can help understanding the effect of DNA methylation on gene expression transcription across cancer stages.

In this article we propose a Bayesian hierarchical model for the identification of differentially expressed genes in Daphnia magna organisms exposed to chemical compounds, specifically munition pollutants in water. The model we propose constitutes one of the very first attempts at a rigorous modeling of the biological effects of water purification. We have data acquired from a purification system that comprises four consecutive purification stages, which we refer to as "ponds," of progressively more contaminated water. We model the expected expression of a gene in a pond as the sum of the mean of the same gene in the previous pond plus a gene-pond specific difference. We incorporate a variable selection mechanism for the identification of the differential expressions, with a prior distribution on the probability of a change that accounts for the available information on the concentration of chemical compounds present in the water. We carry out posterior inference via MCMC stochastic search techniques. In the application, we reduce the complexity of the data by grouping genes according to their functional characteristics, based on the KEGG pathway database. This also increases the biological interpretability of the results. Our model successfully identifies a number of pathways that show differential expression between consecutive purification stages. We also find that changes in the transcriptional response are more strongly associated to the presence of certain compounds, with the remaining contributing to a lesser extent. We discuss the sensitivity of these results to the model parameters that measure the influence of the prior information on the posterior inference.

The effect of a targeted agent on a cancer patient's clinical outcome putatively is mediated through the agent's effect on one or more early biological events. This is motivated by pre-clinical experiments with cells or animals that identify such events, represented by binary or quantitative biomarkers. When evaluating targeted agents in humans, central questions are whether the distribution of a targeted biomarker changes following treatment, the nature and magnitude of this change, and whether it is associated with clinical outcome. Major difficulties in estimating these effects are that a biomarker's distribution may be complex, vary substantially between patients, and have complicated relationships with clinical outcomes. We present a probabilistically coherent framework for modeling and estimation in this setting, including a hierarchical Bayesian nonparametric mixture model for biomarkers that we use to define a functional profile of pre-versus-post-treatment biomarker distribution change. The functional is similar to the receiver operating characteristic used in diagnostic testing. The hierarchical model yields clusters of individual patient biomarker profile functionals, and we use the profile as a covariate in a regression model for clinical outcome. The methodology is illustrated by analysis of a dataset from a clinical trial in prostate cancer using imatinib to target platelet-derived growth factor, with the clinical aim to improve progression-free survival time.

In this article we propose a Bayesian hierarchical model for the identification of differentially expressed genes in Daphnia magna organisms exposed to chemical compounds, specifically munition pollutants in water. The model we propose constitutes one of the very first attempts at a rigorous modeling of the biological effects of water purification. We have data acquired from a purification system that comprises four consecutive purification stages, which we refer to as "ponds," of progressively more contaminated water. We model the expected expression of a gene in a pond as the sum of the mean of the same gene in the previous pond plus a gene-pond specific difference. We incorporate a variable selection mechanism for the identification of the differential expressions, with a prior distribution on the probability of a change that accounts for the available information on the concentration of chemical compounds present in the water. We carry out posterior inference via MCMC stochastic search techniques. In the application, we reduce the complexity of the data by grouping genes according to their functional characteristics, based on the KEGG pathway database. This also increases the biological interpretability of the results. Our model successfully identifies a number of pathways that show differential expression between consecutive purification stages. We also find that changes in the transcriptional response are more strongly associated to the presence of certain compounds, with the remaining contributing to a lesser extent. We discuss the sensitivity of these results to the model parameters that measure the influence of the prior information on the posterior inference.